Literature DB >> 12185142

Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm.

B Fardin1, D J Weissgold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185142      PMCID: PMC1771271          DOI: 10.1136/bjo.86.9.1065

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Am J Ophthalmol       Date:  1990-04-15       Impact factor: 5.258

Review 2.  Retinal pigment epithelial changes associated with systemic corticosteroid treatment: report of cases and review of the literature.

Authors:  C W Spraul; G E Lang; G K Lang
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

3.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

4.  Central serous chorioretinopathy complicating systemic corticosteroid treatment.

Authors:  M Wakakura; S Ishikawa
Journal:  Br J Ophthalmol       Date:  1984-05       Impact factor: 4.638

5.  Central serous chorioretinopathy in endogenous hypercortisolism.

Authors:  E A Bouzas; M H Scott; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-09

6.  Intraocular pressure elevation associated with inhalation and nasal corticosteroids.

Authors:  I Opatowsky; R M Feldman; R Gross; S T Feldman
Journal:  Ophthalmology       Date:  1995-02       Impact factor: 12.079

  6 in total
  6 in total

1.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 2.  Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.

Authors:  Austin S Nakatsuka; Hossein Nazari Khanamiri; Quy N Lam; Jaafar El-Annan
Journal:  Hawaii J Med Public Health       Date:  2019-05

3.  Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.

Authors:  Ge Ge; Yun Zhang; Yichi Zhang; Zhihui Xu; Meixia Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-16       Impact factor: 3.117

4.  Steroid-induced central serous chorioretinopathy in a patient with non-arteritic anterior ischemic optic neuropathy.

Authors:  Zeynep Alkin; Ihsan Yilmaz; Abdullah Ozkaya; Ahmet Taylan Yazici
Journal:  Saudi J Ophthalmol       Date:  2015-01-21

5.  Central Serous Chorioretinopathy: A Complication Associated with Behçet’s Disease Treatment

Authors:  Nur Doğanay; Melike Balıkoğlu Yılmaz; Betül Orduyılmaz; Erdinç Aydın; Ali Osman Saatçi
Journal:  Turk J Ophthalmol       Date:  2019-02-28

6.  Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.

Authors:  Yuh-Shin Chang; Shih-Feng Weng; Jhi-Joung Wang; Ren-Long Jan
Journal:  Int J Environ Res Public Health       Date:  2020-12-17       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.